Scholar Rock Holding Corp.

$SRRK is up over 300% today after the company said a late-stage trial of theirs for the treatment of spinal muscular atrophy met its main goal.

Share this article:

About the Author:

Scholar Rock Holding Corp.

Joey Ramson

PRISM Market View Alerts

Get your dose of PRISM Market
View news, right in your inbox

Mailchimp Signup